Hot Healthcare Stocks: Intrexon Corp (NYSE:XON), Delcath Systems (NASDAQ:DCTH), TearLab Corp (NASDAQ:TEAR), Ventrus Biosciences Inc (NASDAQ:VTUS)

Posted by on May 06, 2014

Board of Directors of Intrexon Corporation (NYSE:XON) accepted the resignation of Thomas D. Reed from his position as director. Dr. Reed will continue to serve as Chief Science Officer of the Company. To fill the vacancy on the Board left by Dr. Reed’s resignation and upon recommendation of its Nominating and Governance Committee, the Board appointed James S. Turley as a non-employee director of the Company. Intrexon Corp (NYSE:XON) opened today at $17.93 and is currently trading at $17.91. The stock showed a negative weekly performance of -3.28%.

Delcath Systems, Inc. (NASDAQ:DCTH) the oncology drug major and medical device developer which holds ownership of the proprietary Melphalan Hepatic Delivery Systems has reported that it will announce its first quarter results on May 7, 2014. Delcath Systems, Inc. (NASDAQ:DCTH) opened at $3.49, in current trading session and currently is at $3.38, by losing -1.43%. The 52 week range of $3.43 – 10.56.Company’s market capitalization is $32.38 billion.

TearLab Corp (NASDAQ:TEAR) announced the appointment of Paul Smith to its senior management team in the newly created position of Vice President, International. TearLab Corp (NASDAQ:TEAR) stock is currently trading at $23. The EPS of the stock is 0.09. Company’s market capitalization is $141.31 billion.

Ventrus Biosciences, Inc. (NASDAQ:VTUS) announced that, in response to a request from the company, the U.S. Food and Drug Administration (FDA) has scheduled a Type B pre-NDA meeting on Thursday, June 19, 2014 at which the company will seek guidance on its planned new drug application (NDA) for DOLIZEM (diltiazem hydrochloride cream) in anal fissures. Ventrus would expect to file an NDA in the second half of 2014 with an anticipated PDUFA date in the second half of 2015 if there is a positive outcome of this pre-NDA meeting. Ventrus Biosciences Inc (NASDAQ:VTUS) stock opened the session at $4.18, and now is at $4.21. The 52 week range of the VTUS stock remained $ 4.05 – 15.18, and the day range was $ 4.16 – 4.21.

Leave a Reply

Your email address will not be published. Required fields are marked *